Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease

American Journal of Pathology

Volumn 149, Issue 2, 1996, Pages 521-529

  Brauchle, Maria ^a   Madlener, Marianne ^a   Wagner, Anna Dorothea ^b   Angermeyer, Karin ^a   Lauer, Ulrich ^b   Hofschneider, Peter Hans ^a   Gregor, Michael ^b   Werner, Sabine ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KERATINOCYTE GROWTH FACTOR;

ARTICLE; CELL PROLIFERATION; CROHN DISEASE; EPITHELIZATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REPAIR; ULCERATIVE COLITIS;

BLOTTING, WESTERN; COLITIS, ULCERATIVE; CROHN DISEASE; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GROWTH SUBSTANCES; HUMANS; ILEUM; IN SITU HYBRIDIZATION; INTERLEUKIN-1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER;

EID: 0030016911     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Rubin JS, Osada H, Finch PW, Taylor G, Rudikoff S, Aaronson SA: Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 1989, 86:802-806
2. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989, 245:752-755
3. Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, Williams LT: Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA 1992, 89:6896-6900
4. Marchese C, Chedid M, Dirsch OR, Csaky KG, Santanelli F, Latini C, LaRochelle WJ, Torrisi MR, Aaronson SA: Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J Exp Med 1995, 182:1369-1376
5. Miki T, Fleming TP, Bottaro DP, Rubin JS. Ron D, Aaronson SA: Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 1991, 251:72-75
6. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM, Aaronson SA: Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 1992, 89:246-250
7. Werner S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH, Williams LT: The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 1994, 266:819-822
8. Werner S, Breeden M, Hübner G, Greenhalgh DG, Longaker MT: Induction of keratinocyte growth factor expression is reduced and delayed in the genetically diabetic mouse. J Invest Dermatol 1994, 103:469-473
9. Brauchle M, Fässler R, Werner S: Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing. J Invest Dermatol 1995, 105:579-584
10. Brauchle M, Angermeyer K, Hübner G, Werner S: Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 1994, 9:3199-3204
11. Chedid M, Rubin JS, Csaky KG, Aaronson SA: Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem 1994, 269:10753-10757
12. Hübner G, Brauchle M, Smola H, Madlener M, Fässler R, Werner S: Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996 (in press)
13. Housley R, Morris CF, Boyle W, Ring B, Blitz R, Tarpley JE, Aukerman SL, Devine PL, Whitehead RH, Pierce GF: Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 1994, 94:1764-1777
14. Podolsky DK: Inflammatory bowel disease. N Engl J Med 1991, 325:928-937
15. Glickman RM: Inflammatory bowel disease. Harrison's Principles of Internal Medicine, ed 13. McGraw-Hill, 1994, pp 1403-1417
16. Gibson PR, Pavli P: Pathogenic factors in inflammatory bowel disease. Dig Dis 1992, 10:17-28
17. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
18. Dell KR, Williams LT: A novel form of fibroblast growth receptor 2: alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity. J Biol Chem 1992, 267:21225-21229
19. Auron PE, Webb AC, Rosenwasser LJ, Mucci SF, Rich A, Wolff SM, Dinarello CA: Nucleotide sequence of human interleukin 1 precursor cDNA. Proc Natl Acad Sci USA 1984:7907-7911
20. Rosenthal A, Chan S, Henzel WM, Haskell C, Kuang W-J, Chen E, Wilcox J, Ullrich A, Goeddel D: Primary structure and mRNA localization of protein F1, a growth-related protein kinase C substrate associated with synaptic plasticity. EMBO J 1987, 12:3641-3646
21. Ligumsky A, Simon PL, Karmeli G, Rachmilewitz D: Role of interleukin 1 in inflammatory bowel disease: enhanced production during active disease. Gut 1990, 31:686-689
22. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S: Cytokine production in patients with inflammatory bowel disease. Gut 1992, 33:933-937
23. Isaacs KL, Sartor RB, Haskin S: Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992, 103:1587-1595
24. McCabe RP, Secrist H, Botney M, Egan M, Peters MG: Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin Immunol Immunopathol 1993, 66:52-58
25. Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y, Yayon A, Givol D, Lonai P: Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev Biol 1993, 58: 475-486
26. Gilbert E, Del Gatto F, Champion-Arnaud P, Gesnel M.-C, Breathnach R: Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA. Mol Cell Biol 1993, 13:5461-5468
27. Mayer L: Mucosal immune system in inflammatory bowel disease. Inflammatory Bowel Disease. Edited by RP MacDermott, W Stenson. New York, Elsevier, 1992, pp 53-75
28. Sartor R: Pathogenesis and clinical relevance of cytokines in inflammatory bowel disease, Immunol Res 1991, 10:465-471
29. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT: Location of tumour necrosis factor-α by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993, 34:1705-1709
30. Reinecker HC, Steffen M, Witthoeft T, Pfluegler I, Schreiber S, MacDermott RP, Raedler A: Enhanced secretion of tumour necrosis factor-α, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993, 94:174-181
31. Gilberts ECAM, Greenstein AJ, Katsel P, Harpaz N, Greenstein RJ: Molecular evidence for two forms of Crohn disease. Proc Natl Acad Sci USA 1995, 91: 12721-12724
32. Frank S, Hübner G, Breier G, Longaker MT, Greenhalgh DG, Werner S: Regulation of vascular endothelial growth factor expression in cultured keratinocytes: implications for normal and impaired wound healing. J Biol Chem 1995, 270:12607-12613